ZURICH (Reuters) - Roche has launched a global cancer immunotherapy Centers of Research Excellence network, saying it will invest up to 100 million Swiss francs ($100.3 million) in the project.
The research network of 21 academic centers around the world is intended to support basic and clinical research collaboration to advance the science of cancer immunotherapy, the Basel-based drugmaker said on Tuesday.
Reporting by John Revill; Editing by Michael Shields
Our Standards: The Thomson Reuters Trust Principles.